• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

OptiMedica

edit

OptiMedica Corporation is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. The company was founded in 2004 with the vision of bringing innovative new technologies to ophthalmologists and transforming existing standards of care.

Since its founding, OptiMedica has been developing a reproducible, noninvasive technique to replace the inconsistent manual steps in cataract surgery with femtosecond laser technology. The system has been designed to deliver new levels of precision, control, performance, and efficacy to cataract surgeons and their patients. OptiMedica has completed clinical trials of its Catalysâ„¢ Precision Laser System, with very promising results reported across these measures. While the Catalys Precision Laser System is not currently for sale in the United States, OptiMedica expects to launch the system in U.S. and international markets in 2011.

Recent Milestones

edit

• 
  OptiMedica received $35M in Series E funding. (5/10/13)
  Posted 5/10/13 at 3:04am via onbiovc.com
• 
  OptiMedica received $35M in Venture Round funding. (11/16/12)
  Posted 11/16/12 at 6:44pm via finsmes.com
• 
  OptiMedica received $16M in Series C funding. (3/26/08)
  Posted 7/10/09 at 12:16am via optimedica.com

Videos

Screenshots

edit

Products

edit

Catalys Precision Laser System

edit

Sources

1. OptiMedica Secures $16 Million in Series C Funding (optimedica.com) [edit]
2. OptiMedica Raises $35M Growth Financing (finsmes.com) [edit]
3. OptiMedica, Corp.: Series E $35M (onbiovc.com) [edit]

Share this page on Twitter or Facebook: Or copy this code to embed a widget: customize »